Last reviewed · How we verify
Assessment of Vivity With French Clinical Data Related to the Toric Model Study (VICTOR)
Presbyopia-correcting implant (PC-IOL): AcrySof IQ Vivity (Alcon) has been evaluated in 2 large pivotal trials (US and OUS trials). These tests showed that this PC-IOL restored intermediate visual acuity (IVA) and near visual acuity (NV A) superior to that of the reference monofocal AcrySof implant. In these tests, it was demonstrated that distance visual acuity (DVA) was non-inferior. However, the intermediate visual acuity for this implant in its toric version has not been evaluated.
Details
| Lead sponsor | Versailles Hospital |
|---|---|
| Status | UNKNOWN |
| Enrolment | 31 |
| Start date | Thu Sep 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Jul 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Cataract